{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910791776703321"]
[null,null,"Titolo",null,"Challenges and opportunities in using residual newborn screening samples for translational research [[electronic resource] ] : workshop summary / / Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academies Press, 2010"]
[null,null,"ISBN",null,"0-309-17713-8"]
[{"$nulls":4},"1-282-91713-7"]
[{"$nulls":4},"9786612917134"]
[{"$nulls":4},"0-309-15955-5"]
[null,null,"Descrizione fisica",null,"1 online resource (85 p.)"]
[null,null,"Disciplina",null,"618.9"]
[null,null,"Soggetti",null,"Genetic disorders - Diagnosis"]
[{"$nulls":4},"Newborn infants - Diseases - Diagnosis"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"Front Matter\"\"; \"\"Reviewers\"\"; \"\"Acknowledgments\"\"; \"\"Contents\"\"; \"\"Abbreviations and Acronyms\"\"; \"\"1 Introduction\"\"; \"\"2 Newborn Screening as a Public Health Program\"\"; \"\"3 Uses of Residual Newborn Screening Samples in Research\"\"; \"\"4 Concerns About the Use of Residual Newborn Screening Samples\"\"; \"\"5 Review and Consent in the Use of Residual Newborn Screening Samples\"\"; \"\"6 Parental and Public Education\"\"; \"\"7 Workshop Overview and Wrap-Up\"\"; \"\"References\"\"; \"\"Appendix A: Workshop Agenda\"\"; \"\"Appendix B: Speaker Biographical Sketches\"\""]
[null,null,null,"Sommario/riassunto","\"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.\""]